SCHEMBL14865763

SCHEMBL14865763

CCCOCCOCC(O)CSCC(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
HTT P42858 2/20 0.41
CYP2C9 P11712 1/20 0.41
HSD17B10 Q99714 4/20 0.38
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 2/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
USP2 O75604 1/20 0.33
PLA2G4B P0C869 1/20 0.32
CYP3A4 P08684 1/20 0.32
TRPA1 O75762 1/20 0.32
LPAR5 Q9H1C0 1/20 0.31
LMNA P02545 2/20 0.31
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865764 0.83 HSD17B10 (0.41) CYP1A2CYP2C19HTTCYP2C9HSD17B10
SCHEMBL14865755 0.77 ALDH1A1 (0.43) HSD17B10ALDH1A1GAAMGAMSI
SCHEMBL14865765 0.76 HSD17B10 (0.42) CYP1A2CYP2C19HTTHSD17B10ALDH1A1
SCHEMBL14865721 0.75 PLA2G4B (0.41) CYP1A2CYP2C19HTTHSD17B10TDP1
SCHEMBL14865730 0.74 PLA2G4B (0.50) CYP1A2CYP2C19HTTUSP2PLA2G4B
SCHEMBL14865692 0.74 PLA2G4B (0.55) CYP1A2CYP2C19HTTHSD17B10TDP1
SCHEMBL14865723 0.72 HSD17B10 (0.44) HTTHSD17B10TDP1USP2PLA2G4B
SCHEMBL17933338 0.71 HSD17B10 (0.50) CYP1A2CYP2C19HTTHSD17B10TDP1
Ethyl Propionate SCHEMBL15618816 0.70 NAAA (0.48) CYP1A2CYP2C19HSD17B10ALDH1A1GAA
SCHEMBL13078918 0.70 CYP1A2 (0.47) CYP1A2CYP2C19HTTCYP2C9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530559-B2 Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites DIC CORPORATION (JP) 2013-09-10 US disclosed
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES DIC CORPORATION (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES AOC3, AOC2, CORO1C CYP1A2 1098/4885CYP2C19 2232/4885HTT 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.